These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 10482184)

  • 1. Metastasis-related genes in prostate cancer.
    Bangma CH; Nasu Y; Ren C; Thompson TC
    Semin Oncol; 1999 Aug; 26(4):422-7. PubMed ID: 10482184
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Elevated expression of caveolin is associated with prostate and breast cancer.
    Yang G; Truong LD; Timme TL; Ren C; Wheeler TM; Park SH; Nasu Y; Bangma CH; Kattan MW; Scardino PT; Thompson TC
    Clin Cancer Res; 1998 Aug; 4(8):1873-80. PubMed ID: 9717814
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Differential metastasis-associated gene analysis of prostate carcinoma cells derived from primary tumor and spontaneous lymphatic metastasis in nude mice with orthotopic implantation of PC-3M cells.
    Chu JH; Sun ZY; Meng XL; Wu JH; He GL; Liu GM; Jiang XR
    Cancer Lett; 2006 Feb; 233(1):79-88. PubMed ID: 15885894
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Caveolin-1 mediates testosterone-stimulated survival/clonal growth and promotes metastatic activities in prostate cancer cells.
    Li L; Yang G; Ebara S; Satoh T; Nasu Y; Timme TL; Ren C; Wang J; Tahir SA; Thompson TC
    Cancer Res; 2001 Jun; 61(11):4386-92. PubMed ID: 11389065
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prostate cancer cells-osteoblast interaction shifts expression of growth/survival-related genes in prostate cancer and reduces expression of osteoprotegerin in osteoblasts.
    Fizazi K; Yang J; Peleg S; Sikes CR; Kreimann EL; Daliani D; Olive M; Raymond KA; Janus TJ; Logothetis CJ; Karsenty G; Navone NM
    Clin Cancer Res; 2003 Jul; 9(7):2587-97. PubMed ID: 12855635
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Enhanced expression of macrophage migration inhibitory factor in prostatic adenocarcinoma metastases.
    Meyer-Siegler K; Hudson PB
    Urology; 1996 Sep; 48(3):448-52. PubMed ID: 8804500
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Primary human prostate cancer cells harboring p53 mutations are clonally expanded in metastases.
    Stapleton AM; Timme TL; Gousse AE; Li QF; Tobon AA; Kattan MW; Slawin KM; Wheeler TM; Scardino PT; Thompson TC
    Clin Cancer Res; 1997 Aug; 3(8):1389-97. PubMed ID: 9815823
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Loss of p53 function leads to metastasis in ras+myc-initiated mouse prostate cancer.
    Thompson TC; Park SH; Timme TL; Ren C; Eastham JA; Donehower LA; Bradley A; Kadmon D; Yang G
    Oncogene; 1995 Mar; 10(5):869-79. PubMed ID: 7534899
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Alterations in gene expression profiles during prostate cancer progression: functional correlations to tumorigenicity and down-regulation of selenoprotein-P in mouse and human tumors.
    Calvo A; Xiao N; Kang J; Best CJ; Leiva I; Emmert-Buck MR; Jorcyk C; Green JE
    Cancer Res; 2002 Sep; 62(18):5325-35. PubMed ID: 12235003
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Liprin-alpha2 gene, protein tyrosine phosphatase LAR interacting protein related gene, is downregulated by androgens in the human prostate cancer cell line LNCaP.
    Fujinami K; Uemura H; Ishiguro H; Kubota Y
    Int J Mol Med; 2002 Aug; 10(2):173-6. PubMed ID: 12119554
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Metastasis-related genes in prostate cancer: the role of caveolin-1.
    Thompson TC
    Cancer Metastasis Rev; 1998-1999; 17(4):439-42. PubMed ID: 10453288
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Suppression of caveolin expression induces androgen sensitivity in metastatic androgen-insensitive mouse prostate cancer cells.
    Nasu Y; Timme TL; Yang G; Bangma CH; Li L; Ren C; Park SH; DeLeon M; Wang J; Thompson TC
    Nat Med; 1998 Sep; 4(9):1062-4. PubMed ID: 9734401
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Heterogeneity of molecular targets on clonal cancer lines derived from a novel hormone-refractory prostate cancer tumor system.
    Freedland SJ; Pantuck AJ; Paik SH; Zisman A; Graeber TG; Eisenberg D; McBride WH; Nguyen D; Tso CL; Belldegrun AS
    Prostate; 2003 Jun; 55(4):299-307. PubMed ID: 12712409
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ovarian cancer G protein-coupled receptor 1, a new metastasis suppressor gene in prostate cancer.
    Singh LS; Berk M; Oates R; Zhao Z; Tan H; Jiang Y; Zhou A; Kirmani K; Steinmetz R; Lindner D; Xu Y
    J Natl Cancer Inst; 2007 Sep; 99(17):1313-27. PubMed ID: 17728215
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Resistance to lysis by cytotoxic T cells: a dominant effect in metastatic mouse prostate cancer cells.
    Lee HM; Timme TL; Thompson TC
    Cancer Res; 2000 Apr; 60(7):1927-33. PubMed ID: 10766182
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification of tumor metastasis suppressor region on the short arm of human chromosome 20.
    Goodarzi G; Mashimo T; Watabe M; Cuthbert AP; Newbold RF; Pai SK; Hirota S; Hosobe S; Miura K; Bandyopadhyay S; Gross SC; Balaji KC; Watabe K
    Genes Chromosomes Cancer; 2001 Sep; 32(1):33-42. PubMed ID: 11477659
    [TBL] [Abstract][Full Text] [Related]  

  • 17. DNA microarray analysis reveals metastasis-associated genes in rat prostate cancer cell lines.
    Reyes I; Tiwari R; Geliebter J; Reyes N
    Biomedica; 2007 Jun; 27(2):190-203. PubMed ID: 17713630
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Synergy of p53 and Rb deficiency in a conditional mouse model for metastatic prostate cancer.
    Zhou Z; Flesken-Nikitin A; Corney DC; Wang W; Goodrich DW; Roy-Burman P; Nikitin AY
    Cancer Res; 2006 Aug; 66(16):7889-98. PubMed ID: 16912162
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In situ prostate cancer gene therapy using a novel adenoviral vector regulated by the caveolin-1 promoter.
    Pramudji C; Shimura S; Ebara S; Yang G; Wang J; Ren C; Yuan Y; Tahir SA; Timme TL; Thompson TC
    Clin Cancer Res; 2001 Dec; 7(12):4272-9. PubMed ID: 11751529
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evolution of the androgen receptor pathway during progression of prostate cancer.
    Hendriksen PJ; Dits NF; Kokame K; Veldhoven A; van Weerden WM; Bangma CH; Trapman J; Jenster G
    Cancer Res; 2006 May; 66(10):5012-20. PubMed ID: 16707422
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.